Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR

C. E. Wainwright*, J. S. Elborn, B. W. Ramsey, G. Marigowda, X. Huang, M. Cipolli, C. Colombo, J. C. Davies, K. De Boeck, P. A. Flume, M. W. Konstan, S. A. McColley, K. McCoy, E. F. McKone, A. Munck, F. Ratjen, S. M. Rowe, D. Waltz, M. P. Boyle

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

930 Scopus citations

Fingerprint

Dive into the research topics of 'Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience

INIS